WEL KID STUDY
Purpose: Determine if taking the study drug colesevelam/placebo will lower the type 2 diabetic's HBA1c over a 6 month period of time.
Recruiting: Individuals ages 10 to 17 years with type 2 diabetes.
TODAY GENETICS STUDY
Purpose: This national study involves collecting biological specimens and family medical history from participants with adolescent onset of type 2 diabetes to explore relationships between possible genetic causes of type 2 diabetes (T2D), as well as obesity, insulin resistance, and cardiovascular complications of insulin resistance.
Recruiting: Individuals of any age who developed type 2 diabetes mellitus before 18 years of age.
Purpose: Determine if type 2 diabetics taking exenatide/placebo will have a change in their HBA1c over a 28 week period of time. This is a twice daily injectable study drug.
Recruiting: Individuals ages 10 to 17 years with type 2 diabetes mellitus.
Purpose: Assess the safety of the addition of sitagliptin, and its effect on hemoglobin A1c in pediatric participants with type 2 diabetes mellitus and inadequate glycemic control.
Recruiting: Individuals ages 10 to 17 years with type 2 diabetes mellitus who have not received treatment with an oral antihyperglycemic agent or insulin for the past 3 months.
Marla Hashiguchi, RN
Phone: (858) 966-8940